• 2025
  Constanze Ciavarella, Chris Drakeley, Ric N Price, Ivo Mueller, Michael T. White, Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics, The Lancet Infectious Diseases, In press, ⟨10.1016/s1473-3099(24)00689-3⟩.
• 2024
  Brault A, Pontais I, Enouf V, Debeuret C, Bloch E, Paireau J, Rameix-Welti MA, White M, Baudemont G, Lina B, Parent du Châtelet I, Casalegno JS, Vaux S, Cauchemez S, Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study., Lancet Child Adolesc Health 2024 Oct; 8(10): 721-729.
• 2024
  Martinez FJ, White M, Guillotte-Blisnick M, Huon C, Boucharlat A, Agou F, England P, Popovici J, Hou MM, Silk SE, Barrett JR, Nielsen CM, Reimer JM, Mukherjee P, Chauhan VS, Minassian AM, Draper SJ, Chitnis CE, PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial., NPJ Vaccines 2024 Jan; 9(1): 10.
• 2023
  Nekkab N, Obadia T, Monteiro WM, Lacerda MVG, White M, Mueller I, Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil., Lancet Reg Health Am 2023 Jun; 22(): 100511.
• 2023
  Woudenberg T, Pinaud L, Garcia L, Tondeur L, Pelleau S, De Thoisy A, Donnadieu F, Backovic M, Attia M, Hozé N, Duru C, Koffi AD, Castelain S, Ungeheuer MN, Fernandes Pellerin S, Planas D, Bruel T, Cauchemez S, Schwartz O, Fontanet A, White M, Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
• 2023
  Kervevan J, Staropoli I, Slama D, Jeger-Madiot R, Donnadieu F, Planas D, Pietri MP, Loghmari-Bouchneb W, Alaba Tanah M, Robinot R, Boufassa F, White M, Salmon-Ceron D, Chakrabarti LA, Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
• 2022
  Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, Duru C, Koffi AD, Castelain S, Fernandes-Pellerin S, Jolly N, De Facci LP, Roux E, Ungeheuer MN, Van Der Werf S, White M, Schwartz O, Fontanet A, Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
• 2022
  Obadia T, Gutierrez-Bugallo G, Duong V, Nuñez AI, Fernandes RS, Kamgang B, Hery L, Gomard Y, Abbo SR, Jiolle D, Glavinic U, Dupont-Rouzeyrol M, Atyame CM, Pocquet N, Boyer S, Dauga C, Vazeille M, Yébakima A, White MT, Koenraadt CJM, Mavingui P, Vega-Rua A, Veronesi E, Pijlman GP, Paupy C, Busquets N, Lourenço-de-Oliveira R, De Lamballerie X, Failloux AB, , Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project., Nat Commun 2022 Aug; 13(1): 4490.
• 2022
  Garcia L, Woudenberg T, Rosado J, Dyer AH, Donnadieu F, Planas D, Bruel T, Schwartz O, Prazuck T, Velay A, Fafi-Kremer S, Batten I, Reddy C, Connolly E, McElheron M, Kennelly SP, Bourke NM, White MT, Pelleau S, , Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
• 2022
  Obadia T, Nekkab N, Robinson LJ, Drakeley C, Mueller I, White MT, , Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment., BMC Med 2022 03; 20(1): 98.
• 2021
  Huber JH, Koepfli C, España G, Nekkab N, White MT, Alex Perkins T, , How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites., Malar J 2021 Dec; 20(1): 479.
• 2021
  Champagne C, Gerhards M, Lana J, García Espinosa B, Bradley C, González O, Cohen JM, Le Menach A, White MT, Pothin E, , Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation., Math Biosci 2021 Dec; 343(): 108750.
• 2021
  Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M, Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 Nov; 224(9): 1489-1499.
• 2021
  Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M, , Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
• 2021
  Minassian AM, Silk SE, Barrett JR, Nielsen CM, Miura K, Diouf A, Loos C, Fallon JK, Michell AR, White MT, Edwards NJ, Poulton ID, Mitton CH, Payne RO, Marks M, Maxwell-Scott H, Querol-Rubiera A, Bisnauthsing K, Batra R, Ogrina T, Brendish NJ, Themistocleous Y, Rawlinson TA, Ellis KJ, Quinkert D, Baker M, Lopez Ramon R, Ramos Lopez F, Barfod L, Folegatti PM, Silman D, Datoo M, Taylor IJ, Jin J, Pulido D, Douglas AD, de Jongh WA, Smith R, Berrie E, Noe AR, Diggs CL, Soisson LA, Ashfield R, Faust SN, Goodman AL, Lawrie AM, Nugent FL, Alter G, Long CA, Draper SJ, , Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination., Med (N Y) 2021 Jun; 2(6): 701-719.e19.
• 2021
  Longley RJ, White MT, Brewster J, Liu ZSJ, Bourke C, Takashima E, Harbers M, Tham WH, Healer J, Chitnis CE, Monteiro W, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I, , IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection., Open Forum Infect Dis 2021 Jun; 8(6): ofab228.
• 2021
  Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T, , Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 05; 2(5): 100275.
• 2021
  Nekkab N, Lana R, Lacerda M, Obadia T, Siqueira A, Monteiro W, Villela D, Mueller I, White M, , Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study., PLoS Med 2021 04; 18(4): e1003535.
• 2021
  Zaloumis SG, Whyte JM, Tarning J, Krishna S, McCaw JM, Cao P, White MT, Dini S, Fowkes FJI, Maude RJ, Kremsner P, Dondorp A, Price RN, White NJ, Simpson JA, , Development and validation of an in silico decision-tool to guide optimisation of intravenous artesunate dosing regimens for severe falciparum malaria patients., Antimicrob Agents Chemother 2021 Mar; (): .
• 2021
  Villasis E, Garro K, Rosas-Aguirre A, Rodriguez P, Rosado J, Gave A, Guzman-Guzman M, Manrique P, White M, Speybroeck N, Vinetz JM, Torres K, Gamboa D, , PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon., Pathogens 2021 Mar; 10(3): .
• 2021
  Niang M, Sandfort M, Mbodj AF, Diouf B, Talla C, Faye J, Sane R, Thiam LG, Thiam A, Badiane A, Vigan-Womas I, Diagne N, Diene Sarr F, Mueller I, Sokhna C, White M, Toure-Balde A, , Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions., Clin Infect Dis 2021 Mar; (): .
• 2021
  Kunkel A, White M, Piola P, , Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis., PLoS Comput Biol 2021 Mar; 17(3): e1008850.
• 2021
  Lana R, Nekkab N, Siqueira AM, Peterka C, Marchesini P, Lacerda M, Mueller I, White M, Villela D, , The top 1%: quantifying the unequal distribution of malaria in Brazil., Malar J 2021 Feb; 20(1): 87.
• 2021
  Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, Meola A, Kerneis S, Terrier B, Fafi-Kremer S, de Seze J, Bruel T, Dejardin F, Petres S, Longley R, Fontanet A, Backovic M, Mueller I, White MT, , Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
• 2021
  Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, Sattabongkot J, Guzman-Guzman M, Llanos-Cuentas A, Vinetz JM, Gamboa D, Mueller I, , Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts., PLoS Negl Trop Dis 2021 02; 15(2): e0009165.
• 2021
  Chotirat S, Nekkab N, Kumpitak C, Hietanen J, White MT, Kiattibutr K, Sa-Angchai P, Brewster J, Schoffer K, Takashima E, Tsuboi T, Harbers M, Chitnis CE, Healer J, Tham WH, Nguitragool W, Mueller I, Sattabongkot J, Longley RJ, , Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand., Front Microbiol 2021 ; 12(): 643501.
• 2020
  Ondigo BN, Hamre KES, Frosch AEP, Ayodo G, White MT, John CC, , Antibody Profiles to P. falciparum Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission., Am J Trop Med Hyg 2020 12; 103(6): 2189-2197.
• 2020
  Sandfort M, Vantaux A, Kim S, Obadia T, Pepey A, Gardais S, Khim N, Lek D, White M, Robinson LJ, Witkowski B, Mueller I, , Forest malaria in Cambodia: the occupational and spatial clustering of Plasmodium vivax and Plasmodium falciparum infection risk in a cross-sectional survey in Mondulkiri province, Cambodia., Malar J 2020 Nov; 19(1): 413.
• 2020
  Martin DL, Saboyà-Díaz MI, Abashawl A, Alemayeh W, Gwyn S, Hooper PJ, Keenan J, Kalua K, Szwarcwald CL, Nash S, Oldenburg C, West SK, White M, Solomon AW, , The use of serology for trachoma surveillance: Current status and priorities for future investigation., PLoS Negl Trop Dis 2020 09; 14(9): e0008316.
• 2020
  Longley RJ, White MT, Takashima E, Brewster J, Morita M, Harbers M, Obadia T, Robinson LJ, Matsuura F, Liu ZSJ, Li-Wai-Suen CSN, Tham WH, Healer J, Huon C, Chitnis CE, Nguitragool W, Monteiro W, Proietti C, Doolan DL, Siqueira AM, Ding XC, Gonzalez IJ, Kazura J, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I, , Development and validation of serological markers for detecting recent Plasmodium vivax infection., Nat. Med. 2020 05; 26(5): 741-749.
• 2020
  Varela ML, Koffi D, White M, Niang M, Mbengue B, Diene Sarr F, Touré AO, Perraut R, Practical example of multiple antibody screening for evaluation of malaria control strategies, Malar. J. 2020 Mar;19(1):117.
• 2020
  Kanoi BN, Nagaoka H, White MT, Morita M, Palacpac NMQ, Ntege EH, Balikagala B, Yeka A, Egwang TG, Horii T, Tsuboi T, Takashima E, , Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population., Front Immunol 2020 ; 11(): 893.
• 2019
  He WQ, Karl S, White MT, Nguitragool W, Monteiro W, Kuehn A, Gruszczyk J, França CT, Sattabongkot J, Lacerda MVG, Tham WH, Mueller I, Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand, PLoS Negl Trop Dis 2019 Aug;13(8):e0007596.
• 2019
  Hay JA, Laurie K, White M, Riley S, Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets, PLoS Comput. Biol. 2019 Aug;15(8):e1007294.
• 2019
  Nguitragool W, Karl S, White M, Koepfli C, Felger I, Singhasivanon P, Mueller I, Sattabongkot J, Highly heterogeneous residual malaria risk in western Thailand, Int. J. Parasitol. 2019 Apr;.
• 2019
  Quah YW, Waltmann A, Karl S, White MT, Vahi V, Darcy A, Pitakaka F, Whittaker M, Tisch DJ, Barry A, Barnadas C, Kazura J, Mueller I, Molecular epidemiology of residual Plasmodium vivax transmission in a paediatric cohort in Solomon Islands, Malar. J. 2019 Mar;18(1):106.
• 2019
  Greenhouse B, Daily J, Guinovart C, Goncalves B, Beeson J, Bell D, Chang MA, Cohen JM, Ding X, Domingo G, Eisele TP, Lammie PJ, Mayor A, Merienne N, Monteiro W, Painter J, Rodriguez I, White M, Drakeley C, Mueller I, , Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination, Gates Open Res 2019;3:131.
• 2019
  White M, Idoko O, Sow S, Diallo A, Kampmann B, Borrow R, Trotter C, Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials, Lancet Infect Dis 2019 Feb;.
• 2019
  Reiling L, Boyle MJ, White MT, Wilson DW, Feng G, Weaver R, Opi DH, Persson KEM, Richards JS, Siba PM, Fowkes FJ, Takashima E, Tsuboi T, Mueller I, Beeson JG, Targets of complement-fixing antibodies in protective immunity against malaria in children, Nat Commun. 2019 Feb 5;10(1):610.
• 2019
  Yman V, White MT, Asghar M, Sundling C, Sondén K, Draper SJ, Osier FHA, Färnert A, Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure., BMC Med 2019 Jan; 17(1): 22.
• 2018
  Pinsent A, Solomon AW, Bailey RL, Bid R, Cama A, Dean D, Goodhew B, Gwyn SE, Jack KR, Kandel RP, Kama M, Massae P, Macleod C, Mabey DCW, Migchelsen S, Müller A, Sandi F, Sokana O, Taoaba R, Tekeraoi R, Martin DL, White MT, The utility of serology for elimination surveillance of trachoma, Nat Commun 2018 Dec;9(1):5444.
• 2018
  Kanoi BN, Nagaoka H, Morita M, White MT, Palacpac NMQ, Ntege EH, Balikagala B, Yeka A, Egwang TG, Horii T, Tsuboi T, Takashima E, Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains, Vaccine 2018 Sep;.
• 2018
  White M, Watson J, Age, exposure and immunity, Elife 2018 Aug;7.
• 2018
  White MT, Walker P, Karl S, Hetzel MW, Freeman T, Waltmann A, Laman M, Robinson LJ, Ghani A, Mueller I, Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax, Nat Commun 2018 Aug;9(1):3300.
• 2018
  White MT, Karl S, Koepfli C, Longley RJ, Hofmann NE, Wampfler R, Felger I, Smith T, Nguitragool W, Sattabongkot J, Robinson L, Ghani A, Mueller I, Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses, Malar. J. 2018 Apr;17(1):170.
• 2017
  Pinsent A, Pepin KM, Zhu H, Guan Y, White MT, Riley S, The persistence of multiple strains of avian influenza in live bird markets, Proc. Biol. Sci. 2017 Dec;284(1868).
• 2017
  Weber GE, White MT, Babakhanyan A, Sumba PO, Vulule J, Ely D, John C, Angov E, Lanar D, Dutta S, Narum DL, Horii T, Cowman A, Beeson J, Smith J, Kazura JW, Dent AE, Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya, Sci Rep 2017 Dec;7(1):16821.
• 2017
  França CT, White MT, He WQ, Hostetler JB, Brewster J, Frato G, Malhotra I, Gruszczyk J, Huon C, Lin E, Kiniboro B, Yadava A, Siba P, Galinski MR, Healer J, Chitnis C, Cowman AF, Takashima E, Tsuboi T, Tham WH, Fairhurst RM, Rayner JC, King CL, Mueller I, Identification of highly-protective combinations of recombinant proteins for vaccine development, Elife 2017 09;6.
• 2017
  Koepfli C, Ome-Kaius M, Jally S, Malau E, Maripal S, Ginny J, Timinao L, Kattenberg JH, Obadia T, White M, Rarau P, Senn N, Barry AE, Kazura JW, Mueller I, Robinson LJ, Sustained Malaria Control Over an 8-Year Period in Papua New Guinea: The Challenge of Low-Density Asymptomatic Plasmodium Infections, J. Infect. Dis. 2017 Dec;216(11):1434-1443.
• 2017
  Longley RJ, White MT, Takashima E, Morita M, Kanoi BN, Li Wai Suen CSN, Betuela I, Kuehn A, Sripoorote P, Franca CT, Siba P, Robinson LJ, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I, Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions, PLoS Negl Trop Dis 2017 Sep;11(9):e0005888.
• 2017
  Golassa L, White MT, Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia, Malar. J. 2017 07;16(1):301.
• 2017
  Longley RJ, França CT, White MT, Kumpitak C, Sa-Angchai P, Gruszczyk J, Hostetler JB, Yadava A, King CL, Fairhurst RM, Rayner JC, Tham WH, Nguitragool W, Sattabongkot J, Mueller I, Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand, Malar. J. 2017 04;16(1):178.
• 2017
  Kanoi BN, Takashima E, Morita M, White MT, Palacpac NM, Ntege EH, Balikagala B, Yeka A, Egwang TG, Horii T, Tsuboi T, Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda, Vaccine 2017 02;35(6):873-881.
• 2017
  White M, Amino R, Mueller I, Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses, Trends Parasitol. 2017 04;33(4):260-263.
• 2016
  White MT, Yeung S, Patouillard E, Cibulskis R, Costs and Cost-Effectiveness of Plasmodium vivax Control, Am. J. Trop. Med. Hyg. 2016 Dec;95(6 Suppl):52-61.
• 2016
  Karl S, White MT, Milne GJ, Gurarie D, Hay SI, Barry AE, Felger I, Mueller I, Spatial Effects on the Multiplicity of Plasmodium falciparum Infections, PLoS ONE 2016;11(10):e0164054.
• 2016
  França CT, Hostetler JB, Sharma S, White MT, Lin E, Kiniboro B, Waltmann A, Darcy AW, Li Wai Suen CS, Siba P, King CL, Rayner JC, Fairhurst RM, Mueller I, An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection, PLoS Negl Trop Dis 2016 05;10(5):e0004639.
• 2016
  Chiu CY, White MT, Healer J, Thompson JK, Siba PM, Mueller I, Cowman AF, Hansen DS, Different Regions of Plasmodium falciparum Erythrocyte-Binding Antigen 175 Induce Antibody Responses to Infection of Varied Efficacy, J. Infect. Dis. 2016 07;214(1):96-104.
• 2015
  Sepúlveda N, Stresman G, White MT, Drakeley CJ, Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication, J Immunol Res 2015;2015:738030.
• 2015
  Penny MA, Verity R, Bever CA, Sauboin C, Galactionova K, Flasche S, White MT, Wenger EA, Van de Velde N, Pemberton-Ross P, Griffin JT, Smith TA, Eckhoff PA, Muhib F, Jit M, Ghani AC, Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models, Lancet 2016 Jan;387(10016):367-375.
• 2015
  Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CS, Hofmann NE, Kinboro B, Waltmann A, Brewster J, Lorry L, Tarongka N, Samol L, Silkey M, Bassat Q, Siba PM, Schofield L, Felger I, Mueller I, Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model, PLoS Med. 2015 Oct;12(10):e1001891.
• 2015
  White MT, Verity R, Churcher TS, Ghani AC, Vaccine approaches to malaria control and elimination: Insights from mathematical models, Vaccine 2015 Dec;33(52):7544-50.
• 2015
  White MT, Verity R, Griffin JT, Asante KP, Owusu-Agyei S, Greenwood B, Drakeley C, Gesase S, Lusingu J, Ansong D, Adjei S, Agbenyega T, Ogutu B, Otieno L, Otieno W, Agnandji ST, Lell B, Kremsner P, Hoffman I, Martinson F, Kamthunzu P, Tinto H, Valea I, Sorgho H, Oneko M, Otieno K, Hamel MJ, Salim N, Mtoro A, Abdulla S, Aide P, Sacarlal J, Aponte JJ, Njuguna P, Marsh K, Bejon P, Riley EM, Ghani AC, Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial, Lancet Infect Dis 2015 Dec;15(12):1450-8.
• 2015
  Walker PG, White MT, Griffin JT, Reynolds A, Ferguson NM, Ghani AC, Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis, Lancet Infect Dis 2015 Jul;15(7):825-32.
• 2015
  Cheke RA, Basáñez MG, Perry M, White MT, Garms R, Obuobie E, Lamberton PH, Young S, Osei-Atweneboana MY, Intsiful J, Shen M, Boakye DA, Wilson MD, Potential effects of warmer worms and vectors on onchocerciasis transmission in West Africa, Philos. Trans. R. Soc. Lond., B, Biol. Sci. 2015 Apr;370(1665).
• 2014
  White MT, Karl S, Battle KE, Hay SI, Mueller I, Ghani AC, Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission, Elife 2014 Nov;3.
• 2014
  Ahmed Ismail H, Tijani MK, Langer C, Reiling L, White MT, Beeson JG, Wahlgren M, Nwuba R, Persson KE, Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria, Malar. J. 2014 Nov;13:425.
• 2014
  Pinsent A, Blake IM, White MT, Riley S, Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time, BMC Infect. Dis. 2014 Aug;14:427.
• 2014
  Imai N, White MT, Ghani AC, Drakeley CJ, Transmission and control of Plasmodium knowlesi: a mathematical modelling study, PLoS Negl Trop Dis 2014 Jul;8(7):e2978.
• 2014
  White MT, Bejon P, Olotu A, Griffin JT, Bojang K, Lusingu J, Salim N, Abdulla S, Otsyula N, Agnandji ST, Lell B, Asante KP, Owusu-Agyei S, Mahama E, Agbenyega T, Ansong D, Sacarlal J, Aponte JJ, Ghani AC, A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine, BMC Med 2014 Jul;12:117.
• 2014
  White MT, Lwetoijera D, Marshall J, Caron-Lormier G, Bohan DA, Denholm I, Devine GJ, Negative cross resistance mediated by co-treated bed nets: a potential means of restoring pyrethroid-susceptibility to malaria vectors, PLoS ONE 2014;9(5):e95640.
• 2014
  White MT, Griffin JT, Akpogheneta O, Conway DJ, Koram KA, Riley EM, Ghani AC, Dynamics of the antibody response to Plasmodium falciparum infection in African children, J. Infect. Dis. 2014 Oct;210(7):1115-22.
• 2013
  Marshall JM, White MT, Ghani AC, Schlein Y, Muller GC, Beier JC, Quantifying the mosquito’s sweet tooth: modelling the effectiveness of attractive toxic sugar baits (ATSB) for malaria vector control, Malar. J. 2013 Aug;12:291.
• 2013
  White MT, Smith DL, Synergism from combinations of infection-blocking malaria vaccines, Malar. J. 2013 Aug;12:280.
• 2013
  White MT, Griffin JT, Ghani AC, The design and statistical power of treatment re-infection studies of the association between pre-erythrocytic immunity and infection with Plasmodium falciparum, Malar. J. 2013 Aug;12:278.
• 2013
  Killeen GF, Seyoum A, Sikaala C, Zomboko AS, Gimnig JE, Govella NJ, White MT, Eliminating malaria vectors, Parasit Vectors 2013 Jun;6:172.
• 2013
  White MT, Bejon P, Olotu A, Griffin JT, Riley EM, Kester KE, Ockenhouse CF, Ghani AC, The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection, PLoS ONE 2013;8(4):e61395.
• 2013
  Bejon P, White MT, Olotu A, Bojang K, Lusingu JP, Salim N, Otsyula NN, Agnandji ST, Asante KP, Owusu-Agyei S, Abdulla S, Ghani AC, Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data, Lancet Infect Dis 2013 Apr;13(4):319-27.
• 2011
  White MT, Conteh L, Cibulskis R, Ghani AC, Costs and cost-effectiveness of malaria control interventions–a systematic review, Malar. J. 2011 Nov;10:337.
• 2011
  White MT, Griffin JT, Churcher TS, Ferguson NM, Basáñez MG, Ghani AC, Modelling the impact of vector control interventions on Anopheles gambiae population dynamics, Parasit Vectors 2011 Jul;4:153.
• 2011
  Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White MJ, Bousema T, Drakeley CJ, Ghani AC, The potential contribution of mass treatment to the control of Plasmodium falciparum malaria, PLoS ONE 2011;6(5):e20179.
• 2010
  White MT, Griffin JT, Riley EM, Drakeley CJ, Moorman AM, Sumba PO, Kazura JW, Ghani AC, John CC, Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines, Proc. Biol. Sci. 2011 May;278(1710):1298-305.
• 2010
  Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W, Bousema T, Drakeley CJ, Ferguson NM, Basáñez MG, Ghani AC, Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies, PLoS Med. 2010 Aug;7(8).
• 2010
  White MT, Griffin JT, Drakeley CJ, Ghani AC, Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials, Malar. J. 2010 Mar;9:82.
• 2009
  Ghani A, Baguelin M, Griffin J, Flasche S, van Hoek AJ, Cauchemez S, Donnelly C, Robertson C, White M, Truscott J, Fraser C, Garske T, White P, Leach S, Hall I, Jenkins H, Ferguson N, Cooper B, The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom, PLoS Curr 2009 Nov;1:RRN1130.
• 2008
  Marioni JC, White M, Tavaré S, Lynch AG, Hidden copy number variation in the HapMap population, Proc. Natl. Acad. Sci. U.S.A. 2008 Jul;105(29):10067-72.